Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTouchstar Plc Regulatory News (TST)

Share Price Information for Touchstar Plc (TST)

Share Price is delayed by 15 minutes
Get Live Data
77.00    2.00 (2.67%)
Bid:
74.00
Ask:
80.00
Spread: 6.00 (8.108%)
Market Cap: £6.10m
TST Live PriceLast checked at - London Stock Exchange

Intraday Touchstar Plc Share Chart

Half Yearly Report

7 Sep 2011 07:00

RNS Number : 7119N
Belgravium Technologies PLC
07 September 2011
Β 

ο»Ώ

Β 

Β 

Β 

Belgravium Technologies plc

Interim Results for the Six Months ended 30 June 2011

Β 

The Board of Belgravium Technologies plc ('Belgravium' or 'the Group'), designers and manufacturers of real-time data capture systems, is pleased to announce Interim results for the six months ended 30 June 2011.

Β 

Key Financials:

30 June 2011 30 June 2010

Β·; Turnover Β£4,773,000 Β£3,657,000

Β·; Profit before tax Β£321,000 Β£26,000

Β·; Basic earnings per share 0.24p 0.03p

Β·; Net Cash/ (Debt) Β£638,000 (Β£711,000)

Β 

Highlights:

Β 

Β 

Commenting on the interim results, John Kembery, Chairman of Belgravium, said:

Β 

"Belgravium has delivered a first half performance in line with expectations and orders received to date mean that the Group will have a second half which is constrained only by supply chain and production capabilities. I am also pleased to report a significant strengthening of our balance sheet which shows net cash of Β£638,000 versus a net debt position of Β£711,000 twelve months ago"

Β 

Β 

For further information please contact:

Β 

Belgravium Technologies Plc

John Kembery: 07770 731021

KPMG Corporate Finance - Nominated Adviser

Christian Mayo: 0113 231 3000

WH Ireland - Broker

Jessica Metcalf: 0113 394 6623

Β 

KPMG Corporate Finance, a division of KPMG LLP which is authorised and regulated by the Financial Services Authority for investment business activities, is acting for the Belgravium as nominated adviser in relation to the matters set out in this announcement and is not acting for any other person in relation to these matters. KPMG Corporate Finance will not be responsible to anyone other than Belgravium for providing the protections afforded to its clients or for providing advice in relation to the contents of this announcement.

Β 

Β 

CHAIRMAN'S INTERIM STATEMENT 2011

Β 

RESULTS

Β 

Belgravium entered 2011 with a stronger order book and better prospects, than for many

years. We have capitalised on these conditions to produce a good interim result with more to come in the second half.

Β 

Sales in the six months period ended 30 June 2011 totalled Β£4,773,000, a 30% improvement over the first half of 2010 (Β£3,657,000). Profit before tax increased to Β£321,000 compared to Β£26,000 in 2010. After tax, this produced earnings of Β£247,000 or basic earnings per ordinary share of 0.24p per share compared to 0.03p per ordinary share in the first half of 2010.

Β 

THE MARKET

The Group is a specialist in providing complete data capture systems for the logistics, petrochemical and mobile retailing markets. There is a large international market for these products both as new systems and as replacement for older equipment. The last three years of financial restraint has not diminished this need but meant that opportunities have been more difficult to convert into orders. Belgravium has responded with a five point strategy aimed at helping the customer to eventually make a decision in our favour. This began to pay off in 2010 with orders reaching into 2011 and it is pleasing to report that the momentum has continued. Competitors do not appear to have faired so well and this should benefit the Group in the longer term, the only uncertainty being the effect of further financial problems in the Eurozone.

Β 

OPERATIONAL REVIEW

Β 

In 2010, we negotiated a contract in France worth €4 million which will run until 2012. In addition, there were two mobile retailing orders early in 2011 and a variety of smaller orders which meant that the Group was significantly busier than in prior years. In the second quarter we gained a contract from Hermes (for delivery in the second half 2011) to replace an existing logistics system as well as a few smaller orders in the petrochemical market. For the second half of the year we have an order for a major airline retailing system, using our hardware and software, which is scheduled to be completed before the year end. Thus, all parts of the business are now working close to full capacity in order to meet this challenging schedule of procurement, assembly and delivery.

Β 

To ensure that we capitalise on improving trends in our markets we have recruited a limited number of technical people and will continue to do so where we find staff of the right calibre and experience.

Β 

BALANCE SHEET

Β 

Cash generation has continued strongly and cash or equivalents at the period end stood out at Β£987,000 compared to Β£161,000 at the end of June 2010. We continue to repay the term loan at a monthly rate which will make the Group free of debt by early 2012. Allowing for the working capital requirements of the large orders in the production pipeline, we will consider paying off the loan slightly ahead of plan, so that the Group ends the year ungeared.

Β 

DIVIDEND

Β 

The Board continues to place high priority on the repayment of the term loan and managing cashflow, therefore, does not think it prudent to pay an interim dividend. However, once the financial needs of the Group are clearer at the year end, we will consider reinstating a final dividend for the current year.

Β 

ACQUISITIONS

Β 

Our growth objectives always included acquisitions aimed at expanding geographic or sectoral coverage. These plans have had to be shelved whilst cash was scarce and our market capitalisation low. Now that the Group will soon be ungeared the time is right to start examining suitable acquisition prospects. We are already examining some opportunities.

Β 

OUTLOOK

Β 

Belgravium has produced results in the first half of 2011 in line with expectations and orders received to date mean that the Group will have a second half which is constrained only by supply chain and production capabilities. Whilst we are mindful of wider economic challenges, our strategic and competitive strength gives us confidence that we are well placed to continue our steady sales and profit improvement in the longer term.

Β 

Β 

Β 

Consolidated income statement

for the six months ended 30 June 2011

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Notes

6 months to

30 June 2011

Total

(Unaudited)

Β£'000

6 months to

30 June 2010

Total

(Unaudited)

Β£'000

Β 

Revenue

Β 

4,773

Β 

3,657

Β 

Operating profit

Β 

334

Β 

56

Β 

Finance income

Β 

1

Β 

-

Β 

Finance costs

Β 

(14)

Β 

(30)

Β 

Profit before tax

Β 

321

Β 

26

Β 

Income tax expense

Β 

Β 

(74)

Β 

-

Profit for the period attributable to equity shareholders

247

26

Β 

Basic earnings per ordinary share (pence)

Β 

2

Β 

0.24

Β 

0.03

Β 

Diluted earnings per ordinary share (pence)

Β 

2

Β 

0.24

Β 

0.03

Β 

Β 

Consolidated statement of changes in equity

for the six months ended 30 June 2011

Called up share capital

Β 

(Unaudited)

Β£'000

Β 

Share premium account (Unaudited) Β£'000

Capital redemption reserve (Unaudited) Β£'000

Profit and loss account

Β 

(Unaudited)

Β£'000

Total

Β 

Β 

(Unaudited)

Β£'000

At 30 June 2010

Β 

5,047

2,932

2,100

(415)

9,664

Profit

Β 

-

-

-

356

356

At 31 December 2010

Β 

5,047

2,932

2,100

(59)

10,020

Profit

Β 

-

-

-

247

247

At 30 June 2011

5,047

2,932

2,100

188

10,267

Β 

Β 

Consolidated balance sheet

at 30 June 2011

As at

30 June 2011 (Unaudited)

Β£'000

As at

30 June 2010 (Unaudited)

Β£'000

At at

31 December 2010 (Audited)

Β£'000

Β 

Β 

Non-current assets

Intangible Assets

Goodwill

9,124

9,124

9,124

Other intangible assets

246

294

278

Property, plant and equipment

248

275

257

9,618

9,693

9,659

Current assets

Inventories

1,574

1,317

1,152

Trade and other receivables

2,627

1,581

3,466

Current tax asset

-

39

12

Cash and cash equivalents

987

161

346

5,188

3,098

4,976

Total assets

14,806

12,791

14,635

Current liabilities

Trade and other payables

4,015

2,199

3,927

Current corporation tax liabilities

97

-

-

Deferred income tax liabilities

61

39

61

Financial liabilities:

Borrowings

Β 

349

Β 

523

Β 

523

Short term provisions

Β 

17

17

17

4,539

2,778

4,528

Β 

Non current liabilities

Financial liabilities:

Borrowings

Β 

Β 

-

Β 

349

Β 

87

Total liabilities

4,539

3,127

4,615

Β 

Capital and reserves attributable to equity holders of the company

Ordinary shares

5,047

5,047

5,047

Share premium reserve

2,932

2,932

2,932

Capital redemption reserve

2,100

2,100

2,100

Profit and loss account

Β 

188

(415)

(59)

Total equity

10,267

9,664

10,020

Total equity and liabilities

14,806

12,791

14,635

Β 

Β 

Consolidated statement of cash flows

For 6 months to 30 June 2011

6 months to

Β 30 June 2011 (Unaudited) Β£'000

6 months to

Β 30 June 2010 (Unaudited) Β£'000

Cash flows from operating activities

Β 

Operating profit

334

56

Depreciation

62

74

Amortisation

66

67

Movement in:

Inventories

(422)

(94)

Trade and other receivables

839

946

Trade and other payables

88

(221)

Cash generated from operations

Β 

967

828

Interest paid

(14)

(30)

Interest received

1

-

Corporation tax received

35

11

Net cash generated from operating activities

Β 

989

809

Cash flows from investing activities

Β 

Expenditure on intangible fixed assets

(34)

(63)

Purchase of property, plant and equipment

Β 

(53)

(33)

Net cash used in investing activities

(87)

(96)

Β 

Cash flows from financing activities

Β 

Repayment of bank borrowings

(261)

Β 

(195)

Net cash used in financing activities

(261)

(195)

Β 

Net increase in cash and cash equivalents

Β 

Β 

641

Β 

518

Cash, cash equivalents and bank overdrafts at the beginning of the period

Β 

346

(357)

Cash, cash equivalents and bank overdrafts at the end of the period

987

161

Β 

Β 

Notes to the interim report

For 6 months to 30 June 2011

Β 

1.

Β 

This financial information comprises the condensed consolidated interim balance sheet as at 30 June 2011 and 30 June 2010 and related consolidated interim statement of income and cash flows for the six months then ended of Belgravium Technologies plc (hereinafter referred to as 'financial information'). Belgravium Technologies plc is listed on the Alternative Investment Market. This financial information for the half year ended 30 June 2011 has neither been audited nor reviewed and does not comprise statutory accounts within the meaning of section 434 of the Companies Act 2006. This financial information was approved by the Board on 6 September 2011.

Β 

This financial information has been prepared in accordance with pronouncements on interim reporting issued by the ASB, AIM rule 18 and the accounting policies set out in the 2010 annual report and financial statements which are prepared in accordance with IFRS as adopted by the European Union. The Group has chosen not to adopt IAS 34 'Interim financial statements' in preparing this financial information. This financial information has been prepared under the historical cost convention.

Β 

The audited accounts for the year ended 31 December 2010 upon which the auditors issued an unqualified opinion, have been delivered to the Registrar of Companies. The audit report on the 2010 accounts did not contain an emphasis of matter paragraph and did not contain a statement made under section 498 of the Companies Act 2006.

Β 

2.

Earnings per ordinary share

2011

(Unaudited)

Β£

2010

(Unaudited)

Β£

Β 

Basic earnings per ordinary share

Β 

Β 0.24p

Β 

0.03p

Diluted earnings per ordinary share

Β 

0.24p

0.03p

Β 

Basic earnings per share is calculated by dividing the earnings attributable to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period.

Β 

For diluted earnings per share the weighted average number of ordinary shares in issue is adjusted to assume conversion of all dilutive ordinary shares. The dilutive ordinary shares represent the share options and warrants granted to employees where the exercise price is less than the average market price of the Company's ordinary shares during the period.

Β 

2011

(Unaudited)

2010

(Unaudited)

Β 

Earnings

Β£'000

Weighted average number of shares

(in thousands)

Β 

Earnings

Β£'000

Weighted

average number of shares (in thousands)

Basic EPS

Earnings attributable to ordinary shareholders

247

100,937

26

100,937

Effect of dilutive securities

Options

-

-

-

-

Β 

Diluted EPS

Adjusted earnings

247

100,937

26

100,937

Β 

3.

Β 

The Company did not declare any dividends in the half year ended 30 June 2011.

Β 

4.

Copies of this statement will be made available to the public at the Company's office:- 2 Campus Road, Listerhills Science Park, Bradford, West Yorkshire, BD7 1HR, or can be obtained from our website at www.belgravium-IR.com

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IR SSAFFMFFSEFU
Date   Source Headline
4th Jun 20262:14 pmRNSDirector/PDMR Shareholding
7th May 20267:00 amRNSResults for the year ended 31 December 2025
24th Mar 202612:00 pmRNSDirector/PDMR Shareholding
5th Mar 20263:30 pmRNSDirector/PDMR Shareholding
25th Feb 20269:49 amRNSDirector/PDMR Shareholding
10th Feb 20263:04 pmRNSDirector/PDMR Shareholding
9th Feb 202612:03 pmRNSDirector/PDMR Shareholding
23rd Jan 20267:00 amRNSDirector/PDMR Shareholding
21st Jan 20267:00 amRNSDirector/PDMR Shareholding
12th Jan 202610:58 amRNSHolding(s) in Company
16th Dec 20257:00 amRNSTrading Update
4th Nov 202512:12 pmRNSHolding(s) in Company
29th Oct 20253:59 pmRNSHolding(s) in Company
29th Oct 20257:00 amRNSTransaction in Own Shares
22nd Oct 20257:00 amRNSTransaction in Own Shares
6th Oct 202510:10 amRNSTransaction in Own Shares
29th Sep 20257:00 amRNSTransaction in Own Shares
22nd Sep 20257:00 amRNSTransaction in Own Shares
16th Sep 20257:00 amRNSInterim Results
8th Sep 20257:00 amRNSTransaction in Own Shares
1st Sep 202511:09 amRNSTransaction in Own Shares & TVR
26th Aug 20258:51 amRNSTransaction in Own Shares
18th Aug 202510:07 amRNSTransaction in Own Shares
11th Aug 20258:16 amRNSTransaction in Own Shares
4th Aug 20258:53 amRNSTransaction in Own Shares
28th Jul 20252:00 pmRNSTransaction in Own Shares
21st Jul 20257:00 amRNSTransaction in Own Shares
15th Jul 20257:00 amRNSTransaction in Own Shares
7th Jul 20257:00 amRNSTransaction in Own Shares
1st Jul 20257:00 amRNSTransaction in Own Shares
30th Jun 20257:00 amRNSTransaction in Own Shares
26th Jun 20257:00 amRNSTransaction in Own Shares
25th Jun 20257:00 amRNSTransaction in Own Shares
24th Jun 202512:28 pmRNSResults of AGM, Business Update & Share Buyback
24th Jun 20257:00 amRNSTransaction in Own Shares
2nd Jun 20257:00 amRNSTransaction in Own Shares
28th May 20257:00 amRNSTransaction in Own Shares
21st May 20257:00 amRNSTransaction in Own Shares
20th May 20257:00 amRNSTransaction in Own Shares
14th May 20257:00 amRNSTransaction in Own Shares
13th May 20257:00 amRNSTransaction in Own Shares
6th May 20259:22 amRNSShare Buyback Programme
29th Apr 20257:00 amRNSFinal Results
17th Apr 20257:00 amRNSNotice of Results & Investor Meet Company
18th Mar 20257:00 amRNSDirectorate Change and Strategic Update
17th Feb 20257:00 amRNSTrading Update & Conclusion of Strategic Review
12th Dec 20244:57 pmRNSForm 8.3 - Touchstar PLC
29th Oct 20247:00 amRNSTrading Update
21st Oct 20247:46 amRNSForm 8.3 - Touchstar plc
16th Oct 20242:35 pmRNSForm 8.3 - Touchstar plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.